Regulatory Updates
🇪🇺 EMA Page 13EMA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global pharma regulatory policy changes, FDA, EMA, and other agency guidelines impacting drug development and market access. Stay ahead.
Showing 145–156 of 171 articles
ESMO Updates Ovarian Cancer Guidelines: Key Changes and Implications
Crinetics Reports $10.3M Palsonify Sales Amid 232 Enrollment Updates
20 Must-Read Highlights from ESMO Breast Cancer Congress 2026
RAPS Euro Convergence: Regulatory Updates & Key Takeaways
RAPS Euro Convergence: Key Regulatory Updates - Day 1
Biosimulation Market to Reach $11.3 Billion by 2031 as Pharmaceutical Companies Accelerate Digital Drug Development
EMA Conditional Marketing Authorizations: 5-Year Review of Oncology Drug Approvals
Accenture Invests in Iridius to Accelerate AI Compliance Solutions for Life Sciences Companies
Veristat Acquires Certara's Regulatory Writing Business to Expand European Market Services
Drug Delivery Devices Market Poised for Significant Growth Through 2032 Driven by Biologics and Regulatory Support
CellCarta Saves 9 Hours Weekly Using RegASK AI Platform for Regulatory Compliance
Continuous Manufacturing in Pharmaceuticals: EU Regulatory Insights & Innovation